Quarterly report pursuant to Section 13 or 15(d)

CONCENTRATIONS (Details Narrative)

v3.24.1.1.u2
CONCENTRATIONS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Apr. 30, 2024
Apr. 30, 2023
Apr. 30, 2024
Apr. 30, 2023
Oct. 31, 2023
Concentration Risk [Line Items]          
Revenue $ 5,323,178 $ 5,301,509 $ 9,784,369 $ 10,897,793  
Accounts receivable 4,402,355   4,402,355   $ 2,643,461
Two Customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]          
Concentration Risk [Line Items]          
Revenue $ 1,530,335   $ 2,199,560 $ 2,517,093  
Concentration risk, percentage 28.70%   22.50% 23.10%  
Two Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]          
Concentration Risk [Line Items]          
Concentration risk, percentage 32.50%   32.50% 38.10%  
Accounts receivable $ 1,429,713 1,483,542 $ 1,429,713 $ 1,483,542  
One Customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]          
Concentration Risk [Line Items]          
Revenue   $ 1,270,138      
Concentration risk, percentage   24.00%      
One Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]          
Concentration Risk [Line Items]          
Concentration risk, percentage   35.10%      
Accounts receivable   $ 1,365,300   $ 1,365,300